Home › Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin...
 

Keywords :   


Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin...

2013-04-17 10:47:14| Chemicals - Topix.net

Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care ... (more)

Tags: iii trial phase bayer

Category:Chemicals

Latest from this category

All news
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
27.09Positive Development for Jotun After First Eight Months of 2028
27.09Graco Signs Definitive Agreement to Acquire Corob
27.09BASF Presents New Corporate Strategy
26.09Advanced Polymer Coatings Signs Deal to Coat for New Build Tankers Union Maritime
26.09Jeff McManus Appointed Senior VP of Americas at allnex
26.09AkzoNobel Develops Particle Technology for Metal Effect Powder Coatings
26.09Behr Paint Company Introduces Women in Paint in Canada
Chemicals »
30.09Farm Progress America, September 30, 2024
30.09Tropical Depression Twelve Graphics
30.09Tropical Depression Joyce Graphics
30.09Tropical Storm Isaac Graphics
30.09Tropical Depression Twelve Forecast Discussion Number 3
30.09Tropical Depression Twelve Wind Speed Probabilities Number 3
30.09Tropical Depression Twelve Public Advisory Number 3
30.09Summary for Tropical Depression Twelve (AT2/AL122024)
More »